Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31145289)

  • 1. Targeted therapy with anlotinib for patient with recurrent glioblastoma: A case report and literature review.
    Lv Y; Zhang J; Liu F; Song M; Hou Y; Liang N
    Medicine (Baltimore); 2019 May; 98(22):e15749. PubMed ID: 31145289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapy with anlotinib for a leptomeningeal spread recurrent glioblastoma patient.
    Li C; Li W; Dai S; Sharma A; Sharma HS; Wu Y
    Prog Brain Res; 2021; 265():407-414. PubMed ID: 34560927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial.
    Lai S; Li P; Liu X; Liu G; Xie T; Zhang X; Wang X; Huang J; Tang Y; Liu Z; Shen G; Li C; Lu F; Wang L; Jiang F; Sun C; Chen Y; Chen M
    Cancer Biol Med; 2024 Mar; 21(5):433-44. PubMed ID: 38445445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3-TACC3 Fusion and Recurrent Glioblastoma.
    Wang Y; Liang D; Chen J; Chen H; Fan R; Gao Y; Gao Y; Tao R; Zhang H
    Oncologist; 2021 Mar; 26(3):173-177. PubMed ID: 32949176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma.
    Huang J; Chaudhary R; Cohen AL; Fink K; Goldlust S; Boockvar J; Chinnaiyan P; Wan L; Marcus S; Campian JL
    J Neurooncol; 2019 May; 142(3):537-544. PubMed ID: 30771200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anlotinib is effective in the treatment of advanced pancreatic cancer: a case report.
    Li S; Niu M; Deng W; Li N; Wei C; Luo S
    Anticancer Drugs; 2022 Jan; 33(1):e558-e561. PubMed ID: 34387586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced intrahepatic cholangiocarcinoma treated using anlotinib and microwave ablation: A case report.
    Zhang A; Liu B; Xu D; Sun Y
    Medicine (Baltimore); 2019 Dec; 98(52):e18435. PubMed ID: 31876723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
    Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
    Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case report.
    Sun L; Yang M; Zhang X; Li H; Wu L; Zhang Y; Cai S
    Medicine (Baltimore); 2020 May; 99(20):e20053. PubMed ID: 32443311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.
    Kalpathy-Cramer J; Chandra V; Da X; Ou Y; Emblem KE; Muzikansky A; Cai X; Douw L; Evans JG; Dietrich J; Chi AS; Wen PY; Stufflebeam S; Rosen B; Duda DG; Jain RK; Batchelor TT; Gerstner ER
    J Neurooncol; 2017 Feb; 131(3):603-610. PubMed ID: 27853960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.
    Xu Q; Huang K; Meng X; Weng Y; Zhang L; Bu L; Zheng X; Cai J; Zhan R; Chen Q
    Clin Cancer Res; 2023 Oct; 29(19):3859-3866. PubMed ID: 37477938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penpulimab and anlotinib in an elderly patient with recurrent cervical cancer: a case report and literature review.
    Niu G; Wang H; Ren Y; Xing X; Zhao L; Liu N; Wen X; Zhai Y
    Immunotherapy; 2023 Aug; 15(12):905-912. PubMed ID: 37340883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy.
    Zhou M; Chen X; Zhang H; Xia L; Tong X; Zou L; Hao R; Pan J; Zhao X; Chen D; Song Y; Qi Y; Tang L; Liu Z; Gao R; Shi Y; Yang Z
    Cancer Commun (Lond); 2019 Jun; 39(1):36. PubMed ID: 31221221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rechallenging Recurrent Glioblastoma with Intra-Arterial Bevacizumab with Blood Brain-Barrier Disruption Results in Radiographic Response.
    Faltings L; Kulason KO; Patel NV; Wong T; Fralin S; Li M; Schneider JR; Filippi CG; Langer DJ; Ortiz R; Boockvar JA
    World Neurosurg; 2019 Nov; 131():234-241. PubMed ID: 31351210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous tamoxifen and dose-dense temozolomide in recurrent glioblastoma.
    DI Cristofori A; Carrabba G; Lanfranchi G; Menghetti C; Rampini P; Caroli M
    Anticancer Res; 2013 Aug; 33(8):3383-9. PubMed ID: 23898108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switch maintenance therapy with anlotinib after chemotherapy in unresectable or metastatic soft tissue sarcoma: a single-center retrospective study.
    Liu J; Deng YT; Jiang Y
    Invest New Drugs; 2021 Apr; 39(2):330-336. PubMed ID: 32974853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of advanced ovarian cancer with anlotinib: a case report.
    Zhang P; Ma L; Wang X; Zhang R; Dong Y
    J Int Med Res; 2020 Dec; 48(12):300060520976824. PubMed ID: 33284728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy opens the blood-brain barrier and synergizes with anlotinib in treating glioblastoma.
    Li PJ; Lai SZ; Jin T; Ying HJ; Chen YM; Zhang P; Hang QQ; Deng H; Wang L; Feng JG; Chen XZ; Guo P; Chen M; Tian Y; Chen YY
    Radiother Oncol; 2023 Jun; 183():109633. PubMed ID: 36963438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway.
    Xu P; Wang H; Pan H; Chen J; Deng C
    Cancer Chemother Pharmacol; 2022 Feb; 89(2):183-196. PubMed ID: 34997858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma Treatment with Temozolomide and Bevacizumab and Overall Survival in a Rural Tertiary Healthcare Practice.
    Carter TC; Medina-Flores R; Lawler BE
    Biomed Res Int; 2018; 2018():6204676. PubMed ID: 30687753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.